BELGIAN INDUSTRY CARDIOVASCULAR MOVE
Astra Pharmaceuticals, Boehringer Mannheim Belgium and Therabel Pharma have launched a cardiovascular prevention campaign in Belgium, in association with family doctors.
The firms have paid for a video aimed at the general population, spelling out the risk factors and urging dietary change. The video will be distributed via the firms' own detailmen to 6,000 family doctors, together with supporting leaflets and posters. Doctors will be asked to loan the videos out to patients, and the campaign, which focuses particularly on cholesterol levels, also includes a call for earlier and more systematic cholesterol testing among the population.
Presenting the campaign, the managing director of Therabel, Paul de Souter, (who is also president of the Belgian drug industry association AGIM) said that the campaign was consistent with the industry's tradition of preventive care, along the following lines:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze